RESEARCH > List of publications

Publications Radue EW, 2008-2010

Articles

Borgwardt SJ, Fusar-Poli P, Radue EW, Riecher-Rössler A. Insular pathology in the at-risk mental state. Eur Arch Psychiatry Clin Neurosci 2008;258: 254-255
Borgwardt SJ, McGuire P, Fusar-Poli P, Radue EW, Riecher-Rössler A. Anterior cingulate pathology in the prodromal stage of schizophrenia. Neuroimage 2008;39(2): 553-4
Garren H, Robinson WH, Krasulova E, Havrdova E, Nadj C, Selmaj K, Losy J, Nadj I, Radue EW, Kidd BA, Gianettoni J, Tersini K, Utz PJ, Valone F, Steinman L. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann Neurol 2008, 63: 611-620
Haller S, Fasler D, Ohlendorf S, Radue EW, Greenlee MW. Neural activation associated with corrective saccades during tasks with fixation, pursuit and saccades. Exp Brain Res 2008;184(1): 83-94
Meckel S, Glücker TM, Kretzschmar M, Scheffler K, Radü EW, Wetzel SG. Display of dural sinuses with time-resolved, contrast-enhanced three-dimensional MR venography. Cerebrovasc Dis 2008;25(3): 217-24
Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pflüger MO, Stieglitz RD, Radue EW, Riecher-Rössler A. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis Schizophr Res 2008;106(2-3):108-14
Borgwardt SJ, Fusar-Poli P, Radue EW, Riecher-Rössler A. Insular pathology in the at-risk mental state. Eur Arch Psychiatry Clin Neurosci 2008;258(4):254-5
Borgwardt SJ, McGuire P, Fusar-Poli P, Radue EW, Riecher-Rössler A. Anterior cingulate pathology in the prodromal stage of schizophrenia. Neuroimage 2008;39(2):553-4
Haller S, Fasler D, Ohlendorf S, Radue EW, Greenlee MW. Neural activation associated with corrective saccades during tasks with fixation, pursuit and saccades. Exp Brain Res 2008;184(1):83-94
Weier K, Naegelin Y, Thoeni A, Hirsch JG, Kappos L, Steinbrich W, Radue EW, Gass A. Non-communicating syringomyelia: a feature of spinal cord involvement in multiple sclerosis. Brain 2008;131(Pt 7):1776-82
Sailer M, Fazekas F, Gass A, Kappos L, Radue EW, Rieckmann P, Toyka K, Wiendl H, Bendszus M. Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis. Rofo 2008;180(11):994-1001
Buehlmann E, Berger GE, Aston J, Gschwandtner U, Pflueger MO, Borgwardt SJ, Radue EW, Riecher-Rössler A. Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study. J Psychiatr Res 2009;[Epub ahead of print]
Sahraian MA, Radue EW, Haller S, Kappos L. Black holes in multiple sclerosis: definition, evolution, and clinical correlations. Acta Neurol Scand 2009;[Epub ahead of print]
Bendfeldt K, Kappos L, Radue EW, Borgwardt SJ. Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis. J Neurol Sci 2009;285(1-2):268-9
Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue EW, Borgwardt SJ. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study. Neuroimage 2009;45(1):60-7
Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, Goodin DS, Pelletier D, Matthews PM, Hauser SL, Kappos L, Polman CH, Oksenberg JR. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009;18(4):767-78
Palmowski-Wolfe AM, Kober C, Berg I, Kunz C, Wetzel S, Buitrago-Téllez C, Radü EW, Scheffler K. Globe restriction in a severely myopic patient visualized through oculodynamic magnetic resonance imaging (od-MRI). J Aapos 2009;13(3):322-4
Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review. Curr Pharm Des 2009;15(22):2535-49
Haller S, Borgwardt SJ, Schindler C, Aston J, Radue EW, Riecher-Rössler A. Can cortical thickness asymmetry analysis contribute to detection of at-risk mental state and first-episode psychosis? A pilot study. Radiology 2009;250(1):212-21
Bloch C, Kaiser A, Kuenzli E, Zappatore D, Haller S, Franceschini R, Luedi G, Radue EW, Nitsch C. The age of second language acquisition determines the variability in activation elicited by narration in three languages in Broca's and Wernicke's area. Neuropsychologia 2009;47(3):625-33
Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radue EW, Metzig C, Bauer L, Lanius V, Sandbrink R, Pohl C, BENEFIT Study Group. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 2009;8(11):987-97
Hutchinson M, Kappos L, Calabresi PA, Confavreux C, Giovannoni G, Galetta SL, Havrdova E, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol 2009;256(3):405-15
Comi G, O'Connor P, Montalban X, Antel J, Radue EW, Karlsson G, Pohlmann H, Aradhye S, Kappos L; FTY720D2201 Study Group. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. Mult Scler 2010;16(2):197-207
Radue EW, et al. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. JNS 2010;(in press)

Book Chapters

Sahraian M.A., Radue EW(2008). MRI Atlas of MS Lesions. Springer-Verlag Heidelberg 2008